Enlivex Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENLV and other ETFs, options, and stocks.About ENLV
Enlivex Therapeutics Ltd. engages in the development of macrophage reprogramming immunotherapy products. It focuses on the development of Allocetra, a universal off-the-shelf cell therapy designed to reprogram macrophages into their homeostatic state.
CEOOren Hershkovitz
CEOOren Hershkovitz
Employees36
Employees36
HeadquartersNess Ziona, Tel Aviv
HeadquartersNess Ziona, Tel Aviv
Founded2012
Founded2012
Employees36
Employees36
ENLV Key Statistics
Market cap218.39M
Market cap218.39M
Price-Earnings ratio-1.69
Price-Earnings ratio-1.69
Dividend yield—
Dividend yield—
Average volume372.79K
Average volume372.79K
High today$0.94
High today$0.94
Low today$0.8211
Low today$0.8211
Open price$0.86
Open price$0.86
Volume465.92K
Volume465.92K
52 Week high$2.10
52 Week high$2.10
52 Week low$0.66
52 Week low$0.66
Stock Snapshot
With a market cap of 218.39M, Enlivex Therapeutics(ENLV) trades at $0.92. The stock has a price-to-earnings ratio of -1.69.
During the trading session on 2026-01-11, Enlivex Therapeutics(ENLV) shares reached a daily high of $0.94 and a low of $0.82. At a current price of $0.92, the stock is +12.0% higher than the low and still -2.1% under the high.
Trading activity shows a volume of 465.92K, compared to an average daily volume of 372.79K.
The stock's 52-week range extends from a low of $0.66 to a high of $2.10.
The stock's 52-week range extends from a low of $0.66 to a high of $2.10.
ENLV News
TipRanks 4d
Enlivex Lists RAIN Treasury Token on KuCoin to Deepen Liquidity and Market AccessClaim 70% Off TipRanks Premium Enlivex ( (ENLV) ) has shared an update. On January 7, 2026, Enlivex Therapeutics announced that its primary digital treasury a...
People also own
Based on the portfolios of people who own ENLV. This list is generated using Robinhood data, and it’s not a recommendation.